Intensity-modulated radiation therapy combined with concomitant temozolomide for brain metastases from lung adenocarcinoma

Short-term efficacy, adverse effects and the impact on quality of life (QoL) of a concomitant treatment with intensity-modulated radiation therapy (IMRT) and temozolomide (TMZ) in patients with brain metastases (BMs) from lung adenocarcinoma were evaluated. This study sought to confirm the benefit o...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jinli, Chai, Xiaoyan, Cao, Ying, Hu, Xiaochu, Zhu, Hongyu, Wang, Jianping, Wu, Yiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126327/
https://www.ncbi.nlm.nih.gov/pubmed/30214562
http://dx.doi.org/10.3892/ol.2018.9171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126327/
https://www.ncbi.nlm.nih.gov/pubmed/30214562
http://dx.doi.org/10.3892/ol.2018.9171

Ejemplares similares